Sunflower Pharmaceuticals Group Co Ltd (002737) — Working Capital to Net Assets Ratio
Sunflower Pharmaceuticals Group Co Ltd (002737) has a Working Capital to Net Assets ratio of 60.7% as of March 2026. Working capital of CN¥2.49 Billion (current assets of CN¥3.56 Billion minus current liabilities of CN¥1.07 Billion) is measured against net assets of CN¥4.11 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 002737 net asset quality score to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Sunflower Pharmaceuticals Group Co Ltd Working Capital to Net Assets (2011–2025)
This chart shows how Sunflower Pharmaceuticals Group Co Ltd's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2011 to 2025. As of March 2026, the ratio stands at 60.7%, reflecting working capital of CN¥2.49 Billion against net assets of CN¥4.11 Billion CNY. Check how tangible is Sunflower Pharmaceuticals Group Co Ltd's equity to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Sunflower Pharmaceuticals Group Co Ltd (2011–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Sunflower Pharmaceuticals Group Co Ltd from 2011 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 002737 stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 58.9% | CN¥2.35 Billion | CN¥3.99 Billion | CN¥3.50 Billion | CN¥1.15 Billion | ▼ -3.4 pp |
| 2024 | 62.3% | CN¥2.86 Billion | CN¥4.59 Billion | CN¥3.89 Billion | CN¥1.03 Billion | ▼ -3.0 pp |
| 2023 | 65.3% | CN¥3.27 Billion | CN¥5.00 Billion | CN¥4.79 Billion | CN¥1.52 Billion | ▲ +4.8 pp |
| 2022 | 60.5% | CN¥2.69 Billion | CN¥4.44 Billion | CN¥4.86 Billion | CN¥2.18 Billion | ▲ +6.1 pp |
| 2021 | 54.4% | CN¥2.14 Billion | CN¥3.94 Billion | CN¥3.39 Billion | CN¥1.25 Billion | ▲ +1.9 pp |
| 2020 | 52.5% | CN¥1.78 Billion | CN¥3.39 Billion | CN¥2.94 Billion | CN¥1.16 Billion | ▲ +0.7 pp |
| 2019 | 51.8% | CN¥1.78 Billion | CN¥3.43 Billion | CN¥3.09 Billion | CN¥1.32 Billion | ▼ -1.7 pp |
| 2018 | 53.5% | CN¥1.84 Billion | CN¥3.44 Billion | CN¥3.05 Billion | CN¥1.21 Billion | ▲ +0.5 pp |
| 2017 | 52.9% | CN¥1.67 Billion | CN¥3.16 Billion | CN¥2.62 Billion | CN¥951.53 Million | ▲ +1.9 pp |
| 2016 | 51.1% | CN¥1.43 Billion | CN¥2.80 Billion | CN¥2.50 Billion | CN¥1.07 Billion | ▲ +4.5 pp |
| 2015 | 46.5% | CN¥1.21 Billion | CN¥2.61 Billion | CN¥2.06 Billion | CN¥849.50 Million | ▼ -19.4 pp |
| 2014 | 65.9% | CN¥1.50 Billion | CN¥2.28 Billion | CN¥2.56 Billion | CN¥1.05 Billion | ▲ +52.8 pp |
| 2013 | 13.1% | CN¥113.53 Million | CN¥869.02 Million | CN¥1.09 Billion | CN¥972.07 Million | ▲ +4.7 pp |
| 2012 | 8.4% | CN¥63.74 Million | CN¥758.39 Million | CN¥1.04 Billion | CN¥971.46 Million | ▲ +13.5 pp |
| 2011 | -5.1% | CN¥-27.63 Million | CN¥543.47 Million | CN¥801.76 Million | CN¥829.38 Million | — |